id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2003-D-0197-0002,FDA,FDA-2003-D-0197,Guideline,Supporting & Related Material,GDL-Guidance,2005-10-19T04:00:00Z,2005,10,,,2008-04-12T00:54:53Z,,0,0,090000648048b7ac
FDA-2003-D-0197-0001,FDA,FDA-2003-D-0197,FDA,Notice,NAD-Notice of Availability of Data,2005-10-19T04:00:00Z,2005,10,2005-10-18T04:00:00Z,,2008-04-12T00:54:53Z,,0,0,090000648048b78f
FDA-2003-D-0197-0003,FDA,FDA-2003-D-0197,Guideline,Supporting & Related Material,GDL-Guidance,2005-10-19T04:00:00Z,2005,10,,,2008-04-12T00:54:53Z,,0,0,090000648048b7ad